Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
34.08
-1.73 (-4.83%)
Sep 9, 2026, 4:00 PM EDT - Market closed
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $1.34 billion as of September 9, 2026. Its market cap has increased by 1,171.95% in one year.
Market Cap
1.34B
Enterprise Value
1.12B
1-Year Change
1,171.95%
Ranking
Category
Stock Price
$34.08
ChartMarket Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $1.34B, an increase of 153.40%. That is a compound annual growth rate of 42.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 1.34B | 142.27% |
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Maze Therapeutics | 1.46B |
| First Tracks Biotherapeutics | 1.45B |
| Alumis | 1.44B |
| Cullinan Therapeutics | 1.42B |
| Replimune Group | 1.42B |
| Alpha Tau Medical | 1.39B |
| Odyssey Therapeutics | 1.38B |
| Omeros | 1.37B |